Search

everythinglearnresearchcommunity

for

Search:↓

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Female hair loss linked to metabolic syndrome, not in males.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

A study found that minoxidil can damage the hearts of dogs and pigs, cautioning its use in humans.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Some herbs show promise as antiandrogenic agents.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Finasteride effectively treats hair loss in transgender men with few side effects.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Men can report their own balding patterns well enough for large health studies.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.